本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kiniksa Pharmaceuticals Ltd.

80.20
+0.82001.03%
盤後80.200.00000.00%16:10 EDT
成交量:40.20萬
成交額:3,214.03萬
市值:62.58億
市盈率:81.01
高:80.86
開:79.36
低:79.13
收:79.38
52周最高:82.94
52周最低:32.89
股本:7,802.40萬
流通股本:4,019.47萬
量比:0.81
換手率:1.00%
股息:- -
股息率:- -
每股收益(TTM):0.9900
每股收益(LYR):0.7500
淨資產收益率:14.04%
總資產收益率:8.05%
市淨率:9.57
市盈率(LYR):106.93

資料載入中...

2025/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/03

重要事件披露

Form 8-K - Current report
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/29

重要事件披露

Form 8-K - Current report
2025/07/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities